Our patented technologies, embedded in established OEM products as ClearSign Core™, and ClearSign Eye™ and other sensing configurations, enhance the performance of combustion systems and fuel safety systems in a broad range of markets, including the energy (upstream oil production and down-stream refining), commercial/industrial boiler, chemical, petrochemical, transport and power industries.
Dr. Bell joined the Board of Directors in 2011. Currently, Dr. Bell is engaged with several emerging, technology driven companies that are characterized by the potential to have global economic impact, address long term societal needs and create strong IP positions. He is a leading expert in the mass production of automotive and thermoelectric products. Five of his inventions have gone into mass production and dominated their target markets. In 1991, Dr. Bell founded Amerigon Inc. now Gentherm (NASDAQ:THRM). Dr. Bell has served many roles in Amerigon, Inc., including Chief Technology Officer until December 2010, Director of Technology until 2000, Chairman and Chief Executive Officer until 1999, and President until 1997. Dr. Bell served as the Chief Executive Officer and President of BSST LLC, a subsidiary of Amerigon from September 2000 to December 2010. Previously, Dr. Bell co-founded Technar Incorporated, which developed and manufactured automotive components, and served as Technar’s Chairman and President until selling majority ownership to TRW Inc. in 1986. Dr. Bell continued managing Technar, then known as TRW Technar, as its President until 1991. He co-founded Mahindra REVA Electric Vehicle Co Ltd. in 1994 and served as its Vice Chairman. Dr. Bell received a B.Sc. in Mathematics, an MSc. in Rocket Propulsion, and a Ph.D. in Mechanical Engineering from the California Institute of Technology. From 2015 to 2019 he served as Chairman Caltech’s Mechanical and Civil Engineering Department External Advisory Board. He is CEO of Ideal Power Inc. (NASDAQ:IPWR) and is Chairman of the Board of Clean Diesel Technologies, Inc. (NASDAQ:CDTI).